Adoptive Transfer of Cloned Melanoma-Reactive T Lymphocytes for the Treatment of Patients with Metastatic Melanoma-Reference-Cited by-同舟云学术

Adoptive Transfer of Cloned Melanoma-Reactive T Lymphocytes for the Treatment of Patients with Metastatic Melanoma

Published:2001-07 Issue:4 Volume:24 Page:363-373
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:Journal of Immunotherapy

Author:

Dudley Mark E.,Wunderlich John,Nishimura Michael I.,Yu David,Yang James C.,Topalian Suzanne L.,Schwartzentruber Douglas J.,Hwu Patrick,Marincola Francesco M.,Sherry Richard,Leitman Susan F.,Rosenberg Steven A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference21 articles.

1. High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

2. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

3. Tumor-specific granulocyte/macrophage colony-stimulating factor and interferon ? secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cells

4. Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.

Cited by 309 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for response to TIL therapy: a comprehensive review;Journal for ImmunoTherapy of Cancer;2024-03

2. CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes;Nature Communications;2024-02-09

3. Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma;Nature Reviews Clinical Oncology;2024-01-08

4. Semi‐Flexible Immunobrushes Facilitate Effective and Selective Expansion of Antigen‐Specific T Cells;Advanced Functional Materials;2023-12-22

5. The molecular perspective on the melanoma and genome engineering of T-cells in targeting therapy;Environmental Research;2023-11